General Information of the Compound
Compound ID |
CP0239872
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(+)-(S)-amphetamine
Show/Hide
|
||||||||||||||||||
Synonyms |
(+)-(S)-Amphetamine
(+)-Phenaminum
(+)-alpha-Methylphenethylamine
(+)-alpha-Methylphenylethylamine
(+/-)-Benzedrine
(+/-)-Desoxynorephedrine
(+/-)-beta-Phenylisopropylamine
(2S)-(+)-Amphetamine
(2S)-1-phenylpropan-2-amine
(S)-(+)-Amphetamine
(S)-(+)-beta-Phenylisopropylamine
(S)-1-Phenyl-2-aminopropane
(S)-1-Phenyl-2-propanamine
(S)-1-Phenyl-2-propylamine
(S)-Amphetamine
(S)-alpha-Methylphenethylamine
(S)-alpha-Phenylethylamine
(S)-alpha-methylbenzeneethanamine
(alphaS)-alpha-methylbenzeneethanamine
51-64-9
Alpha-Methylphenethylamine, d-form
Amsustain
Benzedrine
Benzeneethanamine, alpha-methyl-, (aS)-(9CI)
Beta-phenyl-isopropylamine
D-(+)-Amphetamine
D-(S)-Amphetamine
D-1-Phenyl-2-aminopropan
D-1-Phenyl-2-aminopropan [German]
D-1-Phenyl-2-aminopropane
D-2-Amino-1-phenylpropane
D-AM
D-Amphetamine
D-alpha-methylphenethylamine
Dephadren
Desamfetamina
Desamfetamina [DCIT]
Dexacaps
Dexadrine
Dexamfetamina
Dexamfetamina [INN-Spanish]
Dexamfetamine
Dexamfetamine (INN)
Dexamfetaminum
Dexamfetaminum [INN-Latin]
Dexamphetamine
Dexamphetaminum
Dexamphetaminum [INN-Latin]
Dexanfetamina
Dexanfetamina [INN-Spanish]
Dexedrine
Dexedrine (TN)
Dexedrine Spansule
Dexidrine
Dextro-Amphetamine
Dextro-Amphetamine Sulfate
Dextroamphetamine
Dextroamphetamine (USAN)
Dextroamphetamine [USAN]
Dextroamphetamine resin complex
Dextrostat
Dextrostat (TN)
Dl-1-Phenyl-2-aminopropane
Dl-Amphetamine
Dl-Benzedrine
Fenylo-izopropylaminyl
Isoamycin
Phenethylamine, alpha-methyl-, (+)-(8CI)
Propisamine
Psychedrine
Raphetamine
Rhinalator
S(+)-Amphetamine
Simpatedrin
Sympamin
Sympamine
Sympatedrine
Weckamine
dextroamphetamine
dextroamphetamine sulfate (oral liquid, ADHD), Auriga
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C9H13N
|
||||||||||||||||||
Molecular Weight |
135.21
|
||||||||||||||||||
Canonical SMILES |
C[C@H](N)Cc1ccccc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
KWTSXDURSIMDCE-QMMMGPOBSA-N
|
||||||||||||||||||
CAS |
51-64-9
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00884, Sodium-dependent dopamine transporter
Protein ID: PT01026, Sodium-dependent noradrenaline transporter
Protein ID: PT00871, Sodium-dependent serotonin transporter
Protein ID: PT03226, Trace amine-associated receptor 1
Protein ID: PT03501, Trace amine-associated receptor 1
Cell-based Assay
Protein ID: PT04763, Trace amine-associated receptor 1
Cell-based Assay
Protein ID: PT06422, Trace amine-associated receptor 1
Clinical Information about the Compound